Brief: ProQR Therapeutics, Laboratoires Théa Announce Agreement For Théa To Acquire ProQR's Sepofarsen, Ultevursen Ophthalmic Assets

ProQR Therapeutics NV

01/08/2023 12:08

Aug 1 (Reuters) - ProQR Therapeutics NV  PRQR.O :
    * PROQR THERAPEUTICS AND LABORATOIRES THÉA ANNOUNCE
AGREEMENT FOR
THÉA TO ACQUIRE PROQR’S SEPOFARSEN AND ULTEVURSEN OPHTHALMIC
ASSETS
    * PROQR THERAPEUTICS NV - UNDER TERMS, PROQR WILL RECEIVE AN
INITIAL PAYMENT OF EUR 12.5M
    * PROQR THERAPEUTICS NV - UNDER TERMS, CO WILL ALSO BE
ELIGIBLE
FOR UP TO EUR 135M IN FURTHER DEVELOPMENT, REGULATORY, AND
COMMERCIAL PAYMENTS
    * PROQR THERAPEUTICS NV -  UNDER TERMS, CO WILL ALSO RECEIVE
ADDITIONAL EARN OUTS UP TO HIGH TEENS PERCENTAGE BASED ON
COMMERCIAL SALES IN US AND EU

Source text for Eikon:  ID:nGNX4PQ2Fy 
Further company coverage:  PRQR.O 

 ((Reuters.Briefs@thomsonreuters.com;))